O

Opsidio, LLC

4 employees

Opsidio is a biotechnology company that develops novel biologic therapeutics for patients suffering from fibrotic and allergic diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Severe Asthma
SCF
Fibrosis
Medical
Chronic Kidney Disease
Scleroderma

Date founded

2013

Funding rounds raised

Total raised

$500K

from 2 investors over 2 rounds

O

Opsidio, LLC raised $500K on September 25, 2017

Investors: Mid Atlantic Bio Angels and BioAdvance

FAQ